Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEKINDA for IBS-D
NCT02757105Phase 2Completed
- Sponsor
- RedHill Biopharma
- Start
- May 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ondansetron in Irritable bowel syndrome with diarrhea (IBS-D), sponsored by RedHill Biopharma. Started May 2016; status: completed.
02
Drugs
ondansetron
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT02757105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02757105.